Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
About a year after Aunt Pat’s death, I started the process of collecting my family’s health history, and shared it with my doctor.
New prognostic tests may help thousands of women safely forgo expensive chemotherapy.
Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information.
New genetic testing from Invitae shows how genetic abnormalities in prostate cancer patients can affect both future and family cancer risks.
New database provides information on gene variants to clinicians, researchers and patient advocates around the world.
The first thing the surgeon said when I came out of surgery was that “uterine cancer saved [my] life.”
The goal of developing this type of test “is to safely prevent unnecessary surgeries,” said lead investigator Yuri Nikiforov, MD, PhD.
The agency clarifies how test developers may use clinical evidence in public databases to show that their test is “clinically valid.”
Changing drug treatment based on results from insufficiently substantiated genetic tests could lead to serious health consequences.
Communities focused on specific lung cancer genetic mutations offer patient support and accelerate research.
Findings on nearly 4,000 BRCA1 mutations will be immediately useful to many patients with previously inconclusive genetic test results.
Genetic mutation raises the risk of breast, ovarian and prostate cancers.
Using molecular tests to select the most appropriate treatment leads to better outcomes.
Genetic test can help guide decisions about treatment after surgery.
Nancie Petrucelli is senior genetic counselor at the Karmanos Cancer Institute in Detroit.
IMPRES score identified nearly all patients who responded to checkpoint inhibitors and more than half of those who did not.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.